Flame PR
  • Services
    • Public Relations
    • Digital Marketing
    • Broadcast PR
    • Crisis Management
  • Sectors
    • B2B Technology
    • Cybersecurity
    • Healthcare
    • Fintech
    • Education & Recruitment
    • eCommerce & Retail
  • About
    • About Us
    • Testimonials
    • Portfolio
  • Blog
  • Contact
  • Privacy Policy
  • Services
    • Public Relations
    • Digital Marketing
    • Broadcast PR
    • Crisis Management
  • Sectors
    • B2B Technology
    • Cybersecurity
    • Healthcare
    • Fintech
    • Education & Recruitment
    • eCommerce & Retail
  • About
    • About Us
    • Testimonials
    • Portfolio
  • Blog
  • Contact
  • Privacy Policy

​
​​Flame PR Blog

Akadeum Selects Flame PR to Head US Media Relations

19/9/2023

0 Comments

 

by Oliver Traherne

Picture

We are excited to announce that Akadeum Life Sciences, market leaders in buoyancy-based cell separation, have chosen Flame PR to be their US media relations partner. Flame PR will work with Akadeum to raise awareness of their unique microbubble flotation technology, and how it is set to change the way cancer is diagnosed and treated.

The Michigan-based biotechnology company has broken new ground in cell separation, isolation and expansion technology in recent years, securing $26M in funding so far, and being named in Fast Company’s top 10 most innovative biotechnology companies of 2023.

Flame PR will work hand-in-hand with Akadeum to create dynamic and creative campaigns intended to increase the scientific and financial momentum the life sciences company has developed. The news comes at an exciting moment for Akadeum’s growth strategy as they eye a Series C funding round and clinical trials next year.

Both Flame PR and Akadeum’s work is underpinned by a leadership team that puts people at the heart of their operation, as Brandon McNaughton, PhD., CEO and co-founder of Akadeum comments: “Our people-first philosophy continues to be a crucial component of Akadeum’s success as we head towards Series C funding in the new year.”

Brandon adds, “Flame PR’s exceptional track record of US media relations aligns seamlessly with our vision of becoming the foremost cell separation company in America. Having Flame PR join the Akadeum family is a real boost for the team, and we believe they can take us another step towards realising our vision of accessible and efficacious treatment for patients around the world.”

Kully Dhadda, CEO and founder of Flame PR comments: “Akadeum’s microbubble technology represents the future of cell separation and cancer treatment. We are thoroughly excited to amplify Akadeum’s voice in the media, reaching the CDMOs, cell and gene therapy companies and cancer patients that need Akadeum’s groundbreaking technology the most.”
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Blog Archives:

    May 2025
    April 2025
    February 2025
    November 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    March 2023
    July 2022
    March 2022
    February 2022
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    September 2020
    August 2020
    July 2020
    June 2020
    April 2020
    March 2020
    October 2019
    June 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    December 2016
    October 2016
    September 2016
    August 2016
    July 2016

About     International     Portfolio     Blog     Contact

​
​​37 Pear Tree Street, London, EC1V 3AG
311 West 43rd St, New York, NY 10036


Office: +44 (0) 20 3357 9740 

Mobile: +44 7711 885404

​Sitemap